CLINICAL TRIALS PROFILE FOR ACULAR
✉ Email this page to a colleague
All Clinical Trials for ACULAR
Trial ID | Title | Status | Sponsor | Phase | Start Date | Summary |
---|---|---|---|---|---|---|
NCT00332774 ↗ | Nevanac 3-Month Safety Study With QID Dosing | Completed | Alcon Research | Phase 3 | 2006-02-01 | The purpose of this study is to determine the safety of Nevanac 0.1% compared to Acular LS 0.4% and Vehicle in patients treated before cataract surgery and for approximately 90 days following surgery. |
NCT00333255 ↗ | Nepafenac Opthalmic Suspension 0.1% Compared to Acular LS for Treatment of Inflammation After Cataract Surgery | Completed | Alcon Research | Phase 3 | 2005-09-01 | The purpose of this study is to compare the effectiveness of Nepafenac Ophthalmic Suspension, 0.1% eye drops to Acular LS eye drops, used before and after cataract surgery, for treating inflammation in the eye. |
NCT00335439 ↗ | Effect of Prophylactic Ketorolac on CME After Cataract Surgery | Completed | Queen's University | N/A | 2006-06-01 | The study will evaluate the efficacy of prophylactic administration of the topical nonsteroidal anti-inflammatory drug (NSAID) ketorolac tromethamine 0.5% (AcularĀ®) on cystoid macular edema (CME) in patients having undergone cataract surgery. CME is the most frequent cause of decreased vision after uncomplicated cataract surgery and can result in irreversible sight reduction. The investigation will involve a comparison arm and a treatment arm with both sets of patient populations being evaluated for CME with ophthalmologic examinations and optical coherence tomography (OCT) measurements. The objective is to elucidate the role of NSAID drops in preventing CME after cataract surgery. |
>Trial ID | >Title | >Status | >Sponsor | >Phase | >Start Date | >Summary |
Clinical Trial Conditions for ACULAR
Condition Name
Clinical Trial Locations for ACULAR
Trials by Country
Clinical Trial Progress for ACULAR
Clinical Trial Phase
Clinical Trial Sponsors for ACULAR
Sponsor Name